Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-15 · accession 0001415889-25-004509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +34.7K | 194.1K | +22% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $58.29 | -15.3K | 191.0K | -7% | -$891.4K |
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | -34.7K | 8,526 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | M | A | 20,891 | $0.00 | 196,729 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-16 | F | D | 2,164 | $58.29 | 193,116 | D | — | — | (F4) The reported disposition of 2,164 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2025-02-16 | M | A | 4,263 | $0.00 | 195,280 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-15 | M | A | 3,386 | $0.00 | 177,142 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-15 | F | D | 1,304 | $58.29 | 175,838 | D | — | — | (F1) The reported disposition of 1,304 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 6 | Common | Common Stock | 2025-02-16 | F | D | 8,721 | $58.29 | 188,008 | D | — | — | (F2) The reported disposition of 8,721 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 7 | Common | Common Stock | 2025-02-16 | M | A | 6,112 | $0.00 | 194,120 | D | — | — | |
| 8 | Common | Common Stock | 2025-02-16 | F | D | 3,103 | $58.29 | 191,017 | D | — | — | (F3) The reported disposition of 3,103 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 9 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 6,112 | $0.00 | 6,112 | D | $0.00 · — to — | 6,112 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 10 | Derivative | Performance Stock Units | 2025-02-16 | M | D | 20,891 | $0.00 | 0 | D | $0.00 · — to — | 20,891 Common Stock | (F6) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |
| 11 | Derivative | Restricted Stock Units | 2025-02-15 | M | D | 3,386 | $0.00 | 0 | D | $0.00 · — to — | 3,386 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 12 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 4,263 | $0.00 | 8,526 | D | $0.00 · — to — | 4,263 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |